|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Thursday, February 28
Multiple sclerosis and street cannabis - a study
by
multiplesclerosis
on Thu 28 Feb 2008 01:00 AM CST
A significant minority of patients with multiple sclerosis (MS) use cannabis, yet no study has examined the possible effects on mentation. (mental activity, state of mind) more »
Tuesday, February 26
Study - Clustering of autoimmune diseases in families with a high-risk for MS
by
multiplesclerosis
on Tue 26 Feb 2008 09:02 AM CST
Autoimmune mechanisms are thought to have a major role in the pathogenesis of multiple sclerosis. We aimed to identify coexisting autoimmune phenotypes in patients with multiple sclerosis from families with several members with the disease and more »
Monday, February 25
risk factors and Epstein-Barr virus in multiple sclerosis
by
multiplesclerosis
on Mon 25 Feb 2008 09:52 AM CST
Integrating risk factors. HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. ABSTRACT BACKGROUND: Individuals with high levels of antibodies ... more » Sunday, February 24
soy-based substance might help fight MS
by
multiplesclerosis
on Sun 24 Feb 2008 09:20 AM CST
A natural substance made from soy appears to have amazing restorative powers when given to animals with a multiple sclerosis (MS)-like disease more »
importance of long-term data in multiple sclerosis
by
multiplesclerosis
on Sun 24 Feb 2008 08:42 AM CST
Natural history studies provide important information on the prognosis of multiple sclerosis and on risk factors for long-term outcome and thus help orientate treatment decisions and design clinical trials. Before the introduction of disease-modifying treatment, large longitudinal natural more »
Study - Methylthioadenosine reverses brain autoimmune disease.
by
multiplesclerosis
on Sun 24 Feb 2008 08:32 AM CST
To assess the immunomodulatory activity of methylthioadenosine (MTA) in rodent experimental autoimmune encephalomyelitis (EAE) and in patients with multiple sclerosis.
more »
Saturday, February 23
Possible link between exposure to aluminium and MS
by
multiplesclerosis
on Sat 23 Feb 2008 02:51 PM CST
Their research has demonstrated very high (up to 40 times the control level) urinary excretion of aluminium in MS, particularly so in the relapsing-remitting form of the disease. Urinary excretion of iron was more »
MRI findings predict evolution of preclinical multiple sclerosis
by
multiplesclerosis
on Sat 23 Feb 2008 12:00 AM CST
Patients with subclinical demyelinating lesions fulfilling MRI Barkhof-Tintoré criteria with a normal neurological examination are likely to develop multiple sclerosis (MS), according to a report in the Journal of more »
Friday, February 22
Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
by
multiplesclerosis
on Fri 22 Feb 2008 07:32 AM CST
Barkhof criteria have been adopted to demonstrate dissemination in space in the new multiple sclerosis diagnostic criteria because of their high specificity for predicting conversion to multiple sclerosis. One of the 4 Barkhof criteria is the more »
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
by
multiplesclerosis
on Fri 22 Feb 2008 07:06 AM CST
There is increasing evidence that B lymphocytes are involved in the pathogenesis of multiple sclerosis, and they may be a therapeutic target. Rituximab, a monoclonal antibody, selectively targets more »
Wednesday, February 20
Rituxamab – Effective Against MS in Phase II Trial
by
multiplesclerosis
on Wed 20 Feb 2008 08:33 AM CST
Two doses of rituximab (Rituxan) diminished relapsing-remitting multiple sclerosis lesions and clinical symptoms for nearly a year, researchers more »
Closer to Cure for Multiple Sclerosis and Other Myelin- related Diseases
by
multiplesclerosis
on Wed 20 Feb 2008 08:11 AM CST
A breakthrough finding on the mechanism of myelin formation could have a major impact on the treatment of diseases such as multiple sclerosis and demyelination as a result of more »
Tuesday, February 19
Eli Lilly and BioMS Medical's multiple sclerosis drug MBP8298.
by
multiplesclerosis
on Tue 19 Feb 2008 08:53 AM CST
MBP8298 is currently being evaluated in two pivotal Phase III clinical trials in secondary progressive MS (SPMS) and one Phase II trial in relapsing-remitting MS (RRMS). BioMS will more »
Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis
by
multiplesclerosis
on Tue 19 Feb 2008 03:00 AM CST
To evaluate the efficacy, safety, and tolerability of combination therapy with intramuscular interferon beta-1a and oral doxycycline, a potent inhibitor of more »
Monday, February 18
Treatment of active secondary progressive multiple sclerosis (SPMS) with Treosulfan
by
multiplesclerosis
on Mon 18 Feb 2008 05:02 PM CST
Treosulfan (L-threitol-1,4-bis(methanesulfonate)) is a bifunctional alkylating agent with a favourable profile of side effects, approved for the treatment of ovarian cancer. Treosulfan has previously been shown to reduce the severity more »
|
||
